Prevalence and related factors of the absence of anemia among Chinese chronic hemodialysis patients: a multicenter cross-sectional study
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology,Nephrology
Link
http://link.springer.com/content/pdf/10.1007/s11255-013-0581-1.pdf
Reference19 articles.
1. Kuo CC, Lee CT, Chung CH, Su Y, Chen JB (2005) Recombinant human erythropoietin independence in chronic hemodialysis patients: clinical features, iron homeostasis and erythropoiesis. Clin Nephrol 63:92–97
2. Goodkin DA, Fuller DS, Robinson BM et al (2011) Naturally occurring higher hemoglobin concentration does not increase mortality among hemodialysis patients. J Am Soc Nephrol 22:358–365
3. Verdalles U, Abad S, Vega A, Caro CR, Ampuero J, Jofre R, Lopez-Gomez JM (2011) Factors related to the absence of anemia in hemodialysis patients. Blood Purif 32:69–74
4. Pisoni RL, Gillespie BW, Dickinson DM, Chen K, Kutner MH, Wolfe RA (2004) The dialysis outcomes and Practice patterns Study (DOPPS): design, data elements, and methodology. Am J Kidney Dis 44:7–15
5. Pisoni RL, Bragg-Gresham JL, Young EW et al (2004) Anemia management and outcomes from 12 countries in the dialysis and practice patterns study (DOPPS). Am J Kidney Dis 44:94–111
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinical Indications of Recombinant Human Erythropoietin in a Single Center: A 10-Year Retrospective Study;Frontiers in Pharmacology;2020-07-24
2. Functional erythropoietin‐hepcidin axis in recombinant human erythropoietin independent haemodialysis patients;Nephrology;2019-04-25
3. EFFECTS OF HEPATITIS C SEROPOSITIVITY ON ERYTHROPOIETIN REQUIREMENT IN END-STAGE RENAL FAILURE PATIENTS RECEIVING HEMODIALYSIS;ACTA MEDICA MEDITERR;2018
4. Effect of long period treatment with erythropoiesis stimulating agents on clinically and laboratory parameters in hemodialysis autosomal dominant polycystic kidney disease patients;Revista Romana de Medicina de Laborator;2017-10-26
5. Role of Hepcidin-25 in Chronic Kidney Disease: Anemia and Beyond;Current Medicinal Chemistry;2017-06-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3